Jungova A, Stork M, Spicka I, Radocha J, Minarik J, Pavlicek P, Mihalyova J, Pour L, Straub J, Maisnar V, Pika T, Dekojova T, Soukup J, Popkova T, Mensikova K, Sedlák F, Pospiskova J, Boichuk I, Krhovska P, Stopka T, Jindra P, Jelínek T, Knechtová Z, Capounova V, Latal V, Muronova L, Heindorfer A, Ullrychova J, Sykora M, Kessler P, Hajek R. P25 | REAL-WORLD OUTCOMES IN NEWLY DIAGNOSED MULTIPLE MYELOMA: EVIDENCE SUPPORTING BORTEZOMIB–LENALIDOMIDE–DEXAMETHASONE AS A PREFERRED REGIMEN WITHOUT ANTI-CD38 ANTIBODIES. haematol [Internet]. 2026Apr.15 [cited 2026Apr.21];111(s2). Available from: https://haematologica.org/article/view/haematol.2026.s2.14036